Genzyme Corporation et al v. Gland Pharma Limited > Summary
Court Case Number 1:18-cv-01071
Filing Date Jul 19, 2018
Termination Date Jan 23, 2020
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesKent A. Jordan
Plaintiff
Defendant
Plaintiff Attorneys
11Sanofi
Attorney Name: Jeffrey B. Bove
Buchanan Ingersoll & Rooney PC
Sanofi
Attorney Name: Karen Riesenburger Poppel
Buchanan Ingersoll & Rooney PC
Sanofi Genzyme
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Paula S. Fritsch
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Jeremy E. Noe
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Alison J. Baldwin
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Kurt W. Rohde
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Nicole E. Grimm
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Nathaniel P. Chongsiriwatana
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi Genzyme
Attorney Name: Daniel F. Gelwicks
McDonnell Boehnen Hulbert & Berghoff LLP
Defendant Attorneys
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07897590 | Methods to mobilize progenitor/stem cells | Mar 1, 2011 |
| RE042152 | Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity | Feb 15, 2011 |
| 06987102 | Methods to mobilize progenitor/stem cells | Jan 17, 2006 |
| 06897102 | Process to minimize polysilicon gate depletion and dopant penetration and to increase conductivity | May 24, 2005 |
